Related Experiment Video
Updated: Jan 25, 2026

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
Published on: May 12, 2023
The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity
Syed Moiz Ahmed1, Priya Dharshana Ramani1, Stephen Qi Rong Wong2
1School of Biological Sciences, Nanyang Technological University, Singapore.
Abstract:
The transient build-up of DNA supercoiling during the translocation of replication forks threatens genome stability and is controlled by DNA topoisomerases (TOPs). This crucial process has been exploited with TOP poisons for cancer chemotherapy. However, pinpointing cellular determinants of the best clinical response to TOP poisons still remains enigmatic. Here, we present an integrated approach and demonstrate that endogenous and exogenous expression of the oncofetal high-mobility group AT-hook 2 (HMGA2) protein exhibited broad protection against the formation of hydroxyurea-induced DNA breaks in various cancer cells, thus corroborating our previously proposed model in which HMGA2 functions as a replication fork chaperone that forms a protective DNA scaffold at or close to stalled replication forks. We now further demonstrate that high levels of HMGA2 also protected cancer cells against DNA breaks triggered by the clinically important TOP1 poison irinotecan. This protection is most likely due to the recently identified DNA supercoil constraining function of HMGA2 in combination with exclusion of TOP1 from binding to supercoiled substrate DNA. In contrast, low to moderate HMGA2 protein levels surprisingly potentiated the formation of irinotecan-induced genotoxic covalent TOP1-DNA cleavage complexes. Our data from cell-based and several in vitro assays indicate that, mechanistically, this potentiating role involves enhanced drug-target interactions mediated by HMGA2 in ternary complexes with supercoiled DNA. Subtelomeric regions were found to be extraordinarily vulnerable to these genotoxic challenges induced by TOP1 poisoning, pointing at strong DNA topological barriers located at human telomeres. These findings were corroborated by an increased irinotecan sensitivity of patient-derived xenografts of colorectal cancers exhibiting low to moderate HMGA2 levels. Collectively, we uncovered a therapeutically important control mechanism of transient changes in chromosomal DNA topology that ultimately leads to enhanced human subtelomere stability.
Insights
High-mobility group AT-hook 2 (HMGA2) protein levels influence cancer cell response to DNA topoisomerase (TOP) poisons. High HMGA2 protects against DNA breaks, while low levels potentiate damage, impacting cancer therapy effectiveness.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- DNA topoisomerases (TOPs) regulate DNA supercoiling during replication, a process targeted by chemotherapy drugs.
- Understanding cellular factors influencing TOP poison efficacy is crucial for optimizing cancer treatment.
- The oncofetal protein high-mobility group AT-hook 2 (HMGA2) has been implicated in DNA repair and genome stability.
Purpose of the Study:
- To investigate the role of HMGA2 in protecting cancer cells from DNA damage induced by TOP poisons.
- To elucidate the mechanism by which HMGA2 influences the efficacy of TOP1 inhibitors like irinotecan.
- To explore the therapeutic implications of HMGA2 levels in cancer patient response to irinotecan.
Main Methods:
- Cell-based assays to assess DNA breaks induced by hydroxyurea and irinotecan.
- In vitro assays to study HMGA2 interactions with DNA and TOP1.
- Analysis of HMGA2 expression in patient-derived colorectal cancer xenografts.
- Evaluation of HMGA2's effect on TOP1-DNA cleavage complex formation.
Main Results:
- Endogenous and exogenous HMGA2 expression protected cancer cells from hydroxyurea-induced DNA breaks.
- High HMGA2 levels conferred resistance to irinotecan by constraining DNA supercoils and excluding TOP1.
- Low to moderate HMGA2 levels potentiated irinotecan-induced DNA breaks by enhancing drug-target interactions.
- Subtelomeric regions showed vulnerability to TOP1 poisoning, indicating topological barriers at telomeres.
- Colorectal cancer xenografts with low/moderate HMGA2 exhibited increased irinotecan sensitivity.
Conclusions:
- HMGA2 acts as a protective replication fork chaperone and DNA supercoil constraint factor, influencing cancer cell response to TOP poisons.
- HMGA2 levels dictate sensitivity or resistance to TOP1 inhibitors, presenting a potential biomarker for irinotecan therapy.
- Targeting HMGA2 or understanding its role may lead to novel therapeutic strategies for enhancing cancer treatment efficacy and subtelomere stability.
Related Concept Videos
Inheritance of Chromatin Structures
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Stability of structures
Chromatin Packaging
The chromatin
In combination with specialized DNA binding protein called Histones, the DNA double helix forms a compact DNA: protein complex called chromatin. The chromatin itself is further compacted into higher-order...
Duplication of Chromatin Structure
The basic unit of the chromatin is the nucleosome, consisting of DNA wrapped around octameric histone proteins and short stretches of linker DNA separating individual nucleosomes. The histone proteins within the nucleosome have their...
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...

